Overview

HB10101 Multiple Myeloma

Status:
Recruiting
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
It is a phase one study with dose escalation and safety CART in BCMA- Expressing Multiple Myeloma Patients
Phase:
Phase 1
Details
Lead Sponsor:
Hadassah Medical Organization